The life-sciences imperative
Life sciences is where better research can directly save lives. As an IS-8 priority sector, the UK's pharmaceutical and biotech industries matter for both health outcomes and economic growth.
Drug development is slow and expensive. The average new drug takes more than a decade and billions of pounds to reach the market. Any useful reduction in that cycle has human and economic value.
How Blocks supports life sciences
Research Pipeline Management
Blocks lets research organisations configure how compounds flow through development:
- Visual trial phase builder - Design clinical workflows without code
- Automated regulatory documentation - Generate FDA/EMA submissions
- Real-time trial monitoring - Track patient recruitment and outcomes
- Complete audit trails - GxP-compliant by design
AI-assisted discovery
Our AI tools help researchers:
- Analyse complex biological datasets
- Identify promising compound candidates
- Predict trial outcomes based on historical data
- Automate literature review and analysis
Lab Operations
Blocks streamlines day-to-day research:
- Equipment scheduling and maintenance
- Sample tracking and chain of custody
- Protocol management and reproducibility
- Integration with LIMS and lab equipment
Results for life-sciences companies
A pharmaceutical company using Blocks achieved:
- 40% improvement in trial enrollment
- 30% reduction in regulatory submission time
- Faster early-stage research
Supporting UK life sciences
The UK Government's investment in life sciences recognises the sector's importance. Blocks helps by:
- Speeding research through automation
- Reducing compliance burden with built-in GxP support
- Supporting collaboration across research sites
- Protecting IP with secure data handling